BAMS
GILD icon

Bellevue Asset Management (Switzerland)’s Gilead Sciences GILD Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$24.3M Sell
240,120
-13,930
-5% -$1.45M 3.7% 3
2015
Q3 		$24.9M Buy
254,050
+19,150
+8% +$2.13M 4.07% 1
2015
Q2 		$27.5M Buy
234,900
+1,090
+0.5% +$119K 3.82% 2
2015
Q1 		$22.9M Buy
+233,810
New +$23.7M 3.2% 5

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s GILD Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Gilead Sciences (GILD) stake by 5.5% in Q4 2015, selling an estimated $1.45M and leaving 240,120 shares worth $24.3M. The position accounts for 3.7% of the portfolio, ranked #3.

Bellevue Asset Management (Switzerland) first reported a position in GILD in Q1 2015 and has held it in 4 quarters since. The position peaked at $27.5M in Q2 2015. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 240,120 shares of Gilead Sciences worth $24.3M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) sold 13,930 Gilead Sciences shares in Q4 2015, an estimated $1.45M.
  • Gilead Sciences made up 3.7% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #3 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Gilead Sciences in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Gilead Sciences position peaked at $27.5M in Q2 2015.
  • 1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.